Changes in Opioid Prescribing after CDC Guideline: Michigan Health Lab Interviews Dr. Goldstick
We are excited to offer a new Publication Brief and Visual Abstract based on research findings recently published by Core Faculty and Director of the Center’s Statistics & Methods Section Dr. Jason Goldstick, PhD and team including senior author IPC core faculty Dr. Amy Bohnert, PhD and IPC staff member Matthew Myers, MPH, in JAMA Network Open. In the article, “Changes in Initial Opioid Prescribing Practices After the 2016 Release of the CDC Guideline for Prescribing Opioids for Chronic Pain,” the researchers estimated changes in initial prescribing rates, duration, and dosage practices to opioid-naïve patients following the 2016 CDC guideline release.
The authors found that while reductions in rates of opioid initiation were smaller than projected based on the pre-guideline trend, those who initiated opioids were started at lower average durations and were less likely to be started at high doses, than projected based on the pre-guideline trend. These findings suggest that evidence-based guidelines from trusted sources may affect clinician behavior.